Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from AstraZeneca

AstraZeneca Dumps Off Mid-Stage Cardiovascular Drug To Regio Biosciences

AstraZeneca plc (NASDAQ: AZN) has granted

Benzinga

Covid booster crisis as people with allergies told they can have Pfizer jab

The message that Pfizer was not suitable for people with allergies, especially those with a history of anaphylaxis, spread far and wide - but it is simply not true

Daily Mirror

UK Provides Egypt with 4 Million Doses of AstraZeneca

Egypt has received four million doses of AstraZeneca’s COVID-19 vaccine from the United Kingdom, as part of the global COVAX agreement, Egypt's Health Ministry revealed. The vaccines were sent to Cairo International Airport in three batches on Thursday and Friday. Acting Health Minister Khaled Abdel-Ghaffar thanked the UK for supporting…

Asharq Al-Awsat

From analysis to the latest developments in health,
read the most diverse news in one place.

Omicron-hit may escape reinfection with Delta variant

ICMR conducted a study on 39 individuals, of which 25 had taken both the doses of AstraZeneca COVID-19 vaccine, eight people had taken double dose of Pfizer jab, while six were unvaccinated.

The Hindu

Lisa Shaw's husband reveals she shared birthday with Boris Johnson - and spent final one following rules

The BBC radio presenter passed away due to a complication from the Covid AstraZeneca vaccine

Chronicle Live

Govt rolls out fourth Covid shot in 10 provinces

The government is ramping up the rollout of fourth Covid-19 shots to residents in tourism-dependent regions as the nation gears up for border reopening next month.

Bangkok Post

AstraZeneca Rolls Out "Unprecedented' Three Year Survival Data For Imfinzi/Treme Combo In Liver Cancer

A combination of tremelimumab and AstraZeneca Plc's (NASDAQ: AZN) Imfinzi (durvalumab)

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Death Cross Looms Over AstraZeneca Investors

If history is any guide, there may be trouble ahead for shares of AstraZeneca (NASDAQ:AZN). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Benzinga

Should I mix or match my booster? Your COVID-19 vaccine questions answered

For many Australians, it’s now time for a COVID booster – but which one should you be getting? Read our handy guide to find out.

ABC News

Record year for job-creating digital agency used by AstraZeneca, Royal London and the NHS

Nexer Digital's headcount also increased from 55 in 2020 to 90 at the end of 2021

Birmingham Post

1 … 16 17 18 19

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.